Aufsteiger 2011
Source: Tekmira Pharmaceuticals
Tekmira Provides Corporate Update and Reports 2010 Audited Results
Conference Call at 12 noon Eastern Time Today
VANCOUVER, British Columbia, March 30, 2011 (GLOBE NEWSWIRE)
http://www.globenewswire.com/newsroom/news.html?d=217425
Einige in USA Forum sind auch dieser ansicht.. ;-))
This stock will run to 2-3$ before TLON submit NDA to FDA next Q .
Chart Signals are very strong and super bullish
http://www.barchart.com/cheatsheet.php?sym=TLON
Short Term Indicators Average: 100% Buy
http://www.barchart.com/opinions/stocks/TLON
Mal schauen wie es weiter geht, auf jedem fall ein sehr hohes Volumen das ist immer gut
This is a real unknown gem ,once investors discover this stock it will explode like a nuclear bomb .LOAD UP THE TRUCK WHILE YOU STILL CAN !!
NDA filing for Blockbuster Marqibo next quarter and it could be approved before the end of this Year .
MARKET CAP OF 10 MILLION MAKES ME A BIG LAUGH // TLON WILL MOVE INTO DOUBLE DIGITS IN THE COMING MONTHS !!
Market Cap: $10,4 Mil
Cash: 27,2 Mil
Shares Out: 21,2 Mil
New Presentation // A MUST READ !!
http://biotuesdays.com/2011/02/01/...accelerated-approval-of-marqibo/
Marqibo® is poised for accelerated approval in 4Q 2011
NDA submission and request for priority revue expected in 2Q 2011
Sought indica<on =Adult Ph(-‐)ALL in 2nd relapse or that has failed 2lines of Rx
35% overall response rate as 3rd-6th line treatment in RALLY study
20% complete response rate with impressive median dura<on and survival
.................
http://biotuesdays.com/2011/02/01/...accelerated-approval-of-marqibo/
Talon Therapeutics (OTCBB:TLON) plans to submit a new drug application with the FDA for priority review of its Marqibo oncology drug in the second quarter this year and is hoping for accelerated approval in the final quarter of the year.
“We are seeking accelerated approval based on data from our Phase 2 RALLY study where we demonstrated a 35% overall response rate using single agent Marqibo as third, fourth, fifth or sixth line treatment,” CEO Dr. Steven Deitcher says in an exclusive interview with BioTuesdays.com. “This is the most heavily pretreated and advanced Acute Lymphoblastic Leukemia (ALL) population that has ever been described or studied in the literature.”
If Marqibo is cleared by the FDA for use in additional, larger indications, Talon is looking at a multibillion-dollar potential !
..................................................... .............
Sentiment : Strong Buy
http://messages.finance.yahoo.com/...amp;mid=2609&tof=4&frt=2
vergessen das vor gar nicht so lange her dass 4 fache an Aktien hatte und über 0,60$ wert war..
Das heißt dass viele ein einstieg über 2$ hatten...
Ist da was dran??
Is this the same George Carapella that bilked investors of millions in 2001? Why do all legitimate posts get deleted? I'm out...if it walks and talks like a duck it is...
No NDA to be submitted on this one....look out and watch your back!
SCAM SCAM SCAM SCAM SCAM
Can someone please tell me if this is the same carapella? I need to know before I sell.
http://www.sec.gov/litigation/litreleases/comp17337.htm
Menno 3 leute sind nur an puschen in USA forum *g*
Ein bissien übertrieben was die da tun
erst raten zu kaufen und dann sagen sie mehr oder weniger das sie bei 1$ verkaufen werden
Ob das hilreicht ist?
Insider Roster
CARAPELLA, GEORGE
Director
http://finance.yahoo.com/q/ir?s=TLON.OB+Insider+Roster
und ist der gleiche wie der hier..
http://www.sec.gov/litigation/litreleases/comp17337.htm
Und dies alles ohne News oder Gerüchte !!
Bin mal gespannt, was heute passieren wird.
die letzten news die ich auf der homepage sehe sind vom 13ten mai
da haben über die letzten tage bestimmt nur ein paar leute gewinne eingefahren